Financhill
Sell
32

HST Quote, Financials, Valuation and Earnings

Last price:
$14.64
Seasonality move :
0.96%
Day range:
$14.02 - $14.53
52-week range:
$13.83 - $20.73
Dividend yield:
6.23%
P/E ratio:
14.59x
P/S ratio:
1.79x
P/B ratio:
1.53x
Volume:
9M
Avg. volume:
10.2M
1-year change:
-30.28%
Market cap:
$10.1B
Revenue:
$5.7B
EPS (TTM):
$0.99
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $1.6B $2.9B $4.9B $5.3B $5.7B
Revenue Growth (YoY) -70.38% 78.4% 69.79% 8.23% 7.02%
 
Cost of Revenues $1.1B $1.4B $2.2B $2.5B $2.7B
Gross Profit $487M $1.5B $2.7B $2.9B $3B
Gross Profit Margin 30.06% 51.66% 55.23% 53.66% 53.36%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $89M -- $102M $115M $117M
Other Inc / (Exp) $142M $345M $37M $142M $111M
Operating Expenses $1.4B $1.8B $2B $2.1B $2.3B
Operating Income -$953M -$258M $758M $758M $771M
 
Net Interest Expenses $150M $189M $126M $112M $161M
EBT. Incl. Unusual Items -$961M -$102M $669M $788M $721M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$220M -$91M $26M $36M $14M
Net Income to Company -$741M -$11M $643M $752M $707M
 
Minority Interest in Earnings $9M -- -$10M -$12M -$10M
Net Income to Common Excl Extra Items -$732M -$11M $633M $740M $697M
 
Basic EPS (Cont. Ops) -$1.04 -$0.02 $0.89 $1.04 $0.99
Diluted EPS (Cont. Ops) -$1.04 -$0.02 $0.88 $1.04 $0.99
Weighted Average Basic Share $705.9M $710.3M $714.7M $709.7M $702.1M
Weighted Average Diluted Share $705.9M $710.3M $717.5M $712.8M $704M
 
EBITDA -$138M $851M $1.5B $1.7B $1.7B
EBIT -$803M $89M $825M $975M $936M
 
Revenue (Reported) $1.6B $2.9B $4.9B $5.3B $5.7B
Operating Income (Reported) -$953M -$258M $758M $758M $771M
Operating Income (Adjusted) -$803M $89M $825M $975M $936M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $267M $998M $1.3B $1.3B $1.4B
Revenue Growth (YoY) -79.99% 273.78% 26.55% 4.75% 7.94%
 
Cost of Revenues $205M $462M $581M $623M $665M
Gross Profit $62M $536M $682M $700M $763M
Gross Profit Margin 23.22% 53.71% 54% 52.91% 53.43%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $21M -- -- $35M $36M
Other Inc / (Exp) $155M $300M -$2M $22M -$18M
Operating Expenses $333M $460M $504M $549M $594M
Operating Income -$271M $76M $178M $151M $169M
 
Net Interest Expenses $14M $63M $30M $30M $48M
EBT. Incl. Unusual Items -$130M $313M $146M $143M $103M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$64M -$10M -$3M $9M -$6M
Net Income to Company -$66M $323M $149M $134M $109M
 
Minority Interest in Earnings $2M -$3M -$2M -$2M -$1M
Net Income to Common Excl Extra Items -$64M $320M $147M $132M $108M
 
Basic EPS (Cont. Ops) -$0.09 $0.45 $0.21 $0.19 $0.15
Diluted EPS (Cont. Ops) -$0.09 $0.45 $0.20 $0.19 $0.15
Weighted Average Basic Share $705.3M $714.2M $714.7M $704.6M $699.1M
Weighted Average Diluted Share $705.3M $714.2M $717.8M $710.4M $701.9M
 
EBITDA $52M $541M $355M $378M $359M
EBIT -$115M $376M $189M $192M $162M
 
Revenue (Reported) $267M $998M $1.3B $1.3B $1.4B
Operating Income (Reported) -$271M $76M $178M $151M $169M
Operating Income (Adjusted) -$115M $376M $189M $192M $162M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $1.6B $2.9B $4.9B $5.3B $5.7B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $1.1B $1.4B $2.2B $2.5B $2.7B
Gross Profit $487M $1.5B $2.7B $2.9B $3B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $89M -- -- $115M $117M
Other Inc / (Exp) $142M $345M $37M $143M $111M
Operating Expenses $1.4B $1.8B $2B $2.1B $2.3B
Operating Income -$953M -$258M $758M $758M $771M
 
Net Interest Expenses $150M $189M $126M $113M $161M
EBT. Incl. Unusual Items -$961M -$102M $669M $788M $721M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$220M -$91M $26M $36M $14M
Net Income to Company -$741M -$11M $643M $752M $707M
 
Minority Interest in Earnings $9M -- -$10M -$12M -$10M
Net Income to Common Excl Extra Items -$732M -$11M $633M $740M $697M
 
Basic EPS (Cont. Ops) -$1.03 -$0.03 $0.89 $1.05 $0.99
Diluted EPS (Cont. Ops) -$1.03 -$0.03 $0.88 $1.04 $0.99
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -$138M $851M $1.5B $1.7B $1.7B
EBIT -$803M $89M $825M $976M $936M
 
Revenue (Reported) $1.6B $2.9B $4.9B $5.3B $5.7B
Operating Income (Reported) -$953M -$258M $758M $758M $771M
Operating Income (Adjusted) -$803M $89M $825M $976M $936M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $2.9B $4.9B $5.3B $5.7B --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $1.4B $2.2B $2.5B $2.7B --
Gross Profit $1.5B $2.7B $2.9B $3B --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $73M $77M $115M $117M --
Other Inc / (Exp) $345M $37M $143M $111M --
Operating Expenses $1.8B $2B $2.1B $2.3B --
Operating Income -$258M $758M $758M $771M --
 
Net Interest Expenses $189M $126M $113M $161M --
EBT. Incl. Unusual Items -$102M $669M $788M $721M --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$91M $26M $36M $14M --
Net Income to Company -$11M $643M $752M $707M --
 
Minority Interest in Earnings -- -$10M -$12M -$10M --
Net Income to Common Excl Extra Items -$11M $633M $740M $697M --
 
Basic EPS (Cont. Ops) -$0.03 $0.89 $1.05 $0.99 --
Diluted EPS (Cont. Ops) -$0.03 $0.88 $1.04 $0.99 --
Weighted Average Basic Share $2.8B $2.9B $2.8B $2.8B --
Weighted Average Diluted Share $2.8B $2.9B $2.9B $2.8B --
 
EBITDA $851M $1.5B $1.7B $1.7B --
EBIT $89M $825M $976M $936M --
 
Revenue (Reported) $2.9B $4.9B $5.3B $5.7B --
Operating Income (Reported) -$258M $758M $758M $771M --
Operating Income (Adjusted) $89M $825M $976M $936M --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $2.3B $807M $667M $1.1B $554M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets $2.5B $1.3B $1.4B $1.6B $911M
 
Property Plant And Equipment $10B $10.5B $10.3B $10.2B $11.5B
Long-Term Investments $21M $42M $132M $126M $166M
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $360M $431M $459M $382M $506M
Total Assets $12.9B $12.4B $12.3B $12.2B $13B
 
Accounts Payable $71M $85M $372M $408M $351M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $1.6B $803M $1.4B $1.5B $1.4B
 
Long-Term Debt $4.1B $4.2B $3.2B $3.2B $4.1B
Capital Leases -- -- -- -- --
Total Liabilities $6.5B $5.8B $5.4B $5.4B $6.3B
 
Common Stock $7M $7M $7M $7M $7M
Other Common Equity Adj -$74M -$76M -$75M -$70M -$83M
Common Equity $6.3B $6.4B $6.7B $6.6B $6.6B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $113M $131M $169M $193M $168M
Total Equity $6.4B $6.6B $6.9B $6.8B $6.8B
 
Total Liabilities and Equity $12.9B $12.4B $12.3B $12.2B $13B
Cash and Short Terms $2.3B $807M $667M $1.1B $554M
Total Debt $5.5B $4.9B $4.2B $4.2B $5.1B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $2.3B $807M $667M $1.1B $554M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets $2.5B $1.3B $1.4B $1.6B $911M
 
Property Plant And Equipment $10B $10.5B $10.3B $10.2B $11.5B
Long-Term Investments $21M $42M $132M $126M $166M
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $360M $431M $459M $382M $506M
Total Assets $12.9B $12.4B $12.3B $12.2B $13B
 
Accounts Payable $71M $85M $372M $408M $351M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $1.6B $803M $1.4B $1.5B $1.4B
 
Long-Term Debt $4.1B $4.2B $3.2B $3.2B $4.1B
Capital Leases -- -- -- -- --
Total Liabilities $6.5B $5.8B $5.4B $5.4B $6.3B
 
Common Stock $7M $7M $7M $7M $7M
Other Common Equity Adj -$74M -$76M -$75M -$70M -$83M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $113M $131M $169M $193M $168M
Total Equity $6.4B $6.6B $6.9B $6.8B $6.8B
 
Total Liabilities and Equity $12.9B $12.4B $12.3B $12.2B $13B
Cash and Short Terms $2.3B $807M $667M $1.1B $554M
Total Debt $5.5B $4.9B $4.2B $4.2B $5.1B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$741M -$11M $643M $752M $707M
Depreciation & Amoritzation $665M $762M $664M $697M $762M
Stock-Based Compensation $17M $18M $26M $30M $24M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$307M $292M $1.4B $1.4B $1.5B
 
Capital Expenditures $499M $427M $504M $646M $548M
Cash Acquisitions -- -$1.5B -$301M $5M -$1.5B
Cash From Investing -$195M -$1.2B -$618M -$183M -$2B
 
Dividends Paid (Ex Special Dividend) -$320M -- -$150M -$547M -$737M
Special Dividend Paid
Long-Term Debt Issued $3B $443M -- -- $2.2B
Long-Term Debt Repaid -$1.2B -$1.2B -$685M -$7M -$1.3B
Repurchase of Common Stock -$169M -- -$27M -$182M -$107M
Other Financing Activities -$53M -$38M -$12M -$35M -$46M
Cash From Financing $1.2B -$657M -$874M -$771M -$13M
 
Beginning Cash (CF) $1.8B $2.5B $953M $874M $1.4B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $729M -$1.5B -$76M $487M -$555M
Ending Cash (CF) $2.5B $953M $874M $1.4B $798M
 
Levered Free Cash Flow -$806M -$135M $912M $795M $950M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders -$153M $118M $291M $272M --
Depreciation & Amoritzation $165M $172M $169M $180M --
Stock-Based Compensation $4M $5M $7M $6M --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$49M $261M $308M $365M --
 
Capital Expenditures $93M $122M $146M $103M --
Cash Acquisitions -$189M -- -- -- --
Cash From Investing -$275M -$92M -$105M -$100M --
 
Dividends Paid (Ex Special Dividend) -- -- -$228M -$316M --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- $300M --
Long-Term Debt Repaid -- -$683M -- -- --
Repurchase of Common Stock -- -- -$50M -- --
Other Financing Activities -$11M -$10M -$30M -$28M --
Cash From Financing -$11M -$693M -$308M -$44M --
 
Beginning Cash (CF) $2.5B $953M $874M $1.4B --
Foreign Exchange Rate Adjustment -- $1M $1M -$2M --
Additions / Reductions -$335M -$524M -$105M $221M --
Ending Cash (CF) $2.1B $430M $770M $1.6B --
 
Levered Free Cash Flow -$142M $139M $162M $262M --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$741M -$11M $643M $752M $707M
Depreciation & Amoritzation $665M $762M $664M $697M $762M
Stock-Based Compensation $17M $18M $26M $30M $24M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$307M $292M $1.4B $1.4B $1.5B
 
Capital Expenditures $499M $427M $504M $646M $548M
Cash Acquisitions -- -$1.5B -- $5M -$1.5B
Cash From Investing -$195M -$1.2B -$618M -$183M -$2B
 
Dividends Paid (Ex Special Dividend) -$320M -- -$150M -$547M -$737M
Special Dividend Paid
Long-Term Debt Issued $3B -- -- -- $2.2B
Long-Term Debt Repaid -- -$1.2B -$685M -- --
Repurchase of Common Stock -$169M -- -$27M -$182M -$107M
Other Financing Activities -$53M -$38M -$12M -$35M -$46M
Cash From Financing $1.2B -$657M -$874M -$771M -$13M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $729M -$1.5B -$76M $487M -$555M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$806M -$135M $912M $795M $950M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders -$153M $118M $291M $272M --
Depreciation & Amoritzation $165M $172M $169M $180M --
Stock-Based Compensation $4M $5M $7M $6M --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$49M $261M $308M $365M --
 
Capital Expenditures $93M $122M $146M $103M --
Cash Acquisitions -$189M -- -- -- --
Cash From Investing -$275M -$92M -$105M -$100M --
 
Dividends Paid (Ex Special Dividend) -- -- -$228M -$316M --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- $300M --
Long-Term Debt Repaid -- -$683M -- -- --
Repurchase of Common Stock -- -- -$50M -- --
Other Financing Activities -$11M -$10M -$30M -$28M --
Cash From Financing -$11M -$693M -$308M -$44M --
 
Beginning Cash (CF) $2.5B $953M $874M $1.4B --
Foreign Exchange Rate Adjustment -- $1M $1M -$2M --
Additions / Reductions -$335M -$524M -$105M $221M --
Ending Cash (CF) $2.1B $430M $770M $1.6B --
 
Levered Free Cash Flow -$142M $139M $162M $262M --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Should I Buy Alcoa Stock?
Should I Buy Alcoa Stock?

Alcoa (AA) finds itself in an interesting position in early…

Where Will Nu Holdings Stock Be in 2030?
Where Will Nu Holdings Stock Be in 2030?

Despite fast growth, high profitability and an extraordinary runway ahead,…

Is it Too Late to Buy United Airlines Stock?
Is it Too Late to Buy United Airlines Stock?

United Airlines (NASDAQ:UAL) has thoroughly outpaced the broader stock market…

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 37x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
42
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 37x

Alerts

Buy
78
GATE alert for Apr 2

Marblegate Acquisition [GATE] is up 86.64% over the past day.

Buy
52
NUTX alert for Apr 2

Nutex Health [NUTX] is up 5.41% over the past day.

Buy
75
CORT alert for Apr 2

Corcept Therapeutics [CORT] is down 8.84% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock